Best Alkylating Drug for rhabdomyosarcoma
4 Alkylating Drug drugs indicated for rhabdomyosarcoma, ranked by our independent rating. The current highest-rated is ivra. Compare them with all treatments for rhabdomyosarcoma or the full Alkylating Drug class. Not medical advice — always consult a professional.
Top alkylating drug for rhabdomyosarcoma: 1. Ivra · 2. Evomela · 3. Hepzato
| # | Drug | Rating | Type | Typical price | |
|---|---|---|---|---|---|
| 1 | Ivra | 62/100 | Prescription | — | View → |
| 2 | Evomela | Not yet rated | Prescription | — | View → |
| 3 | Hepzato | Not yet rated | Prescription | — |
Full ranking · 4 drugs
Frequently asked
- What is the best alkylating drug for rhabdomyosarcoma?
- By our independent rating, ivra currently ranks highest among Alkylating Drug drugs used for rhabdomyosarcoma. Ratings are based on FDA regulatory (recall-safety) data — always consult a professional.
- Which alkylating drug drugs treat rhabdomyosarcoma?
- pharmaranks lists 4 Alkylating Drug products indicated for rhabdomyosarcoma, per FDA drug-label data — each independently rated and ranked above.
- How are these ranked?
- By our independent score, currently based on FDA regulatory recall-safety data (the methodology blends additional sources as they come online). See the How we rate page.